ZDA
AGN

Zweig-DiMenna Associates’s Allergan plc AGN Stock Holding History

Zweig-DiMenna Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-317,095
Closed -$56.2M – 132
2020
Q1 		$56.2M Buy
317,095
+90,600
+40% +$17.1M 7.44% 1
2019
Q4 		$43.3M Sell
226,495
-24,040
-10% -$4.34M 4.32% 3
2019
Q3 		$42.2M Buy
250,535
+127,482
+104% +$20.8M 3.74% 3
2019
Q2 		$20.6M Buy
+123,053
New +$17M 1.96% 13
2019
Q1 		– Sell
-1,500
Closed -$200K – 154
2018
Q4 		$200K Buy
+1,500
New +$246K 0.02% 119
2017
Q3 		– Sell
-38,657
Closed -$9.4M – 257
2017
Q2 		$9.4M Buy
+38,657
New +$9.08M 0.69% 61
2017
Q1 		– Sell
-141,890
Closed -$29.8M – 255
2016
Q4 		$29.8M Buy
141,890
+8,652
+6% +$1.79M 2.14% 4
2016
Q3 		$30.7M Buy
133,238
+38,951
+41% +$9.52M 2.49% 6
2016
Q2 		$21.8M Sell
94,287
-14,715
-13% -$3.39M 2.23% 11
2016
Q1 		$29.2M Sell
109,002
-152,706
-58% -$43.7M 2.58% 10
2015
Q4 		$81.8M Sell
261,708
-5,952
-2% -$1.77M 4.08% 1
2015
Q3 		$72.8M Buy
267,660
+164,040
+158% +$50.4M 3.15% 4
2015
Q2 		$31.4M Sell
103,620
-134,751
-57% -$40.2M 1.74% 11
2015
Q1 		$70.9M Buy
238,371
+86,944
+57% +$24.8M 2.97% 3
2014
Q4 		$39M Sell
151,427
-42,895
-22% -$10.7M 1.68% 13
2014
Q3 		$46.9M Sell
194,322
-15,123
-7% -$3.38M 2.05% 6
2014
Q2 		$46.7M Buy
209,445
+110,445
+112% +$22.9M 2.13% 9
2014
Q1 		$20.4M Buy
+99,000
New +$19.6M 1.2% 27

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Zweig-DiMenna Associates's AGN Position: Q2 2020 in Review

Zweig-DiMenna Associates sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 317,095 shares — an estimated $56.2M sold.

Zweig-DiMenna Associates first reported a position in AGN in Q1 2014 and held it in 18 quarters. The position peaked at $81.8M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Zweig-DiMenna Associates reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 317,095 Allergan plc shares in Q2 2020, an estimated $56.2M.
  • Zweig-DiMenna Associates first reported a position in Allergan plc in Q1 2014 and held it in 18 quarters.
  • Zweig-DiMenna Associates's Allergan plc position peaked at $81.8M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2020, filed 29 Jul 2020.